SCHEMBL24188237

SCHEMBL24188237

CC(C)N1CC(N2CCc3ccccc32)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.55
▸ OPRD1 P41143 1/20 0.55
▸ OPRK1 P41145 1/20 0.55
▸ OPRL1 P41146 1/20 0.55
▸ HTR2C P28335 4/20 0.44
▸ HTR2B P41595 3/20 0.44
▸ ALDH1A1 P00352 5/20 0.43
▸ USP2 O75604 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ CDK4 P11802 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CCND1 P24385 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SIGMAR1 Q99720 3/20 0.42
▸ LMNA P02545 3/20 0.40
▸ GAA P10253 3/20 0.40
▸ GFER P55789 2/20 0.40
▸ SCD O00767 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24762571 0.81 OPRM1 (0.51) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL11822358 0.77 SIGMAR1 (0.51) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL8275622 0.77 OPRM1 (0.54) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL3723794 0.77 OPRM1 (0.65) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL1868714 0.76 OPRM1 (0.57) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL2675996 0.75 OPRM1 (0.62) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL4934890 0.73 HTR2C (0.58) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL30681350 0.71 OPRM1 (0.48) OPRM1OPRD1OPRK1OPRL1HTR2C
SCHEMBL18920981 0.71 OPRM1 (1.00) OPRM1OPRD1OPRK1OPRL1
SCHEMBL20230231 0.71 OPRM1 (1.00) OPRM1OPRD1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858925-B2 GAS41 inhibitors and methods of use thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-01-02 — — US disclosed
US-11858925-B2 GAS41 inhibitors and methods of use thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-01-02 — — US disclosed
US-20220017509-A1 GAS41 INHIBITORS AND METHODS OF USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-01-20 — — US disclosed
WO-2022010537-A1 GAS41 INHIBITORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2022-01-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11858925-B2 GAS41 inhibitors and methods of use thereof GAS6, HIF1AN, TMEM41B OPRM1 4574/4885OPRD1 4652/4885OPRK1 4647/4885
US-20220017509-A1 GAS41 INHIBITORS AND METHODS OF USE THEREOF GAS6, HIF1AN, TMEM41B OPRM1 4574/4885OPRD1 4652/4885OPRK1 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback